⏰ Last chance to submit your research! Abstract submissions for the EASL Liver Cancer Summit 2027 close tomorrow, 13 October. Bring your latest findings to Valencia and contribute to the multidisciplinary discussions advancing liver cancer research and care. 📍 Valencia, Spain 📅 14-16 January 2027 Submit your abstract today: easl.eu/event/easl-liver-can… Learn more: easl.eu/event/easl-liver-can…

The liver cancer community is coming together at the EASL #LiverCancerSummit 2027! 📅 14–16 January 2027 📍 Valencia, Spain Join experts from across the field to explore the latest advances in basic, translational and clinical liver cancer research, and their potential to transform patient care. 📣 Two important deadlines are approaching: 🔬 Submit your abstract by 13 October 🎟️ Register with early fees by 20 October Share your research, exchange knowledge and be part of the conversations shaping the future of liver cancer care. 👉 Learn more, submit your abstract and register: easl.eu/event/easl-liver-can… @DebbieShawcros1 @analleo @PinterMatthias @CrocettiLaura @SaborowskiAnna

⭐️The EASL #LiverCancerSummit 2027 in Valencia, Spain brings together the liver cancer community to explore the latest advances in basic, translational, and clinical research, and their potential to transform patient care. Spanning the full continuum of primary liver cancers, the programme takes you from prevention and early detection to innovative treatment strategies and long-term patient management. Join experts and peers from across the field to exchange knowledge, foster collaboration, and accelerate progress towards better outcomes for patients with liver cancer. 🗣️“It is an opportunity for all of us to increase our knowledge in the management of these diseases - you cannot miss it.” 👉Early registration fee until 20 October: easl.eu/event/liver-cancer-s… 👉Abstract submission until 13 October: easl.eu/event/liver-cancer-s… 👉Scientific Programme: easl.eu/event/liver-cancer-s… @PinterMatthias @SaborowskiAnna @DebbieShawcros1 @analleo

✨The full scientific programme for #EASLCongress 2026 is now live! From late breaking science and state of the art lectures to interactive workshops, skills learning and multidisciplinary discussions, the programme captures the full scope and momentum of modern hepatology. With more than 8,000 delegates set to gather in Barcelona on 26-30 May, now is the time to explore the sessions, discover speakers and start shaping your personal Congress experience. Explore the full programme and start planning today! 🔗 easl.us1.list-manage.com/tra… @DebbieShawcros1 @analleo

⭐️As the EASL #LiverCancerSummit comes to an end, a sincere thank you to all organisers, faculty, industry partners, and our 598 participants for three outstanding days of science, collaboration and shared commitment to improving outcomes for people with liver cancer, that unfolded in Edinburgh. An inspiring meeting, and a strong platform for what comes next! We look forward to seeing you again in Valencia on 14-16 January 2027! 👉Registered delegates can access content from the Summit on demand: easl-lcs.virtual-meeting.org… @josepmllovet @IreneBargellini @DJPinato @PinterMatthias @EASLedu

📄Share your new findings and connect with the liver community by submitting an abstract to the #EASLCongress 2026, taking place on 27-30 May in Barcelona! With more than 2,000 submissions last year, it is a great place to showcase your work. Take this chance to join an international event, add your ideas to the discussion and be considered for awards. 👉Send your abstract by 6 January 2026! easlcongress.eu/2026-abstrac… @DebbieShawcros1 @analleo @aelsharkawy75 @RuiCastroHD @bogdanprocopet @fprusso73 @SaSi_Lens @PinterMatthias

🚨 Last chance for early registration! Be part of the EASL #LiverCancerSummit 2026, a leading event dedicated to advancing the science and care of liver cancer. Join world-renowned experts, researchers, and clinicians to explore the latest breakthroughs, evolving standards of care, and key controversies in HCC and related malignancies. 🗓 Early fee deadline: TOMORROW, 28 October 🔗 Don’t miss out – register today and secure your spot at a reduced rate! easl.eu/event/liver-cancer-s… 💙 EASL Members enjoy even greater discounts – become a member and benefit now. @DebbieShawcros1 @analleo @IreneBargellini @josepmllovet @DJPinato @PinterMatthias

🚨 Last call for abstracts! Tomorrow, 21 October, is the final deadline to submit your work for the EASL #LiverCancerSummit 2026. Don’t miss the chance to share your latest research, connect with global experts, and shape the future of liver cancer care. The Summit will bring together the international liver oncology community to explore the latest advances in research, clinical practice, and innovation. Join us and be part of the conversation driving progress in liver oncology! 👉easl.eu/event/liver-cancer-s… @DebbieShawcros1 @analleo @josepmllovet @PinterMatthias @DJPinato @IreneBargellini

HCC neuroendocrine transition refers to the rare process where HCC develops features of neuroendocrine tumors, leading to more aggressive disease and challenging treatment decisions. Register now to join the upcoming EASL Molecular Tumour Board to explore what this means for clinical management and research: easl-eu.zoom.us/webinar/regi… Faculty @VChernyakMD, @ma5RN, @MarcoSanduzzi, @siadaniela and @Vaital73 are looking forward to discussing these cases! #LiverTwitter #LiverX

🌟 We are thrilled to announce that registration and abstract submission are now officially open for #EASLCongress 2026! 📍 Taking place in Barcelona, Spain, from 27–30 May 2026, this is the must-attend event for all who are passionate about advancing hepatology. Whether you are a clinician, researcher, policymaker, or trainee, EASL Congress offers something for everyone. 🔬 What makes EASL Congress 2026 unmissable? - A scientific programme covering every track in hepatology: clinical practice, basic science, translational research, and public health. - Diverse formats that allow you to engage with the content most relevant to your expertise. 📢 Abstract submission is open until 6 January 2026 easlcongress.eu/2026-abstrac… 💡 Early bird registration is open until 13 January 2026 easlcongress.eu/2026-registr… 🔗easlcongress.eu #LiverTwitter #LiverX

⏳ Less than one month left to submit your abstract! Be part of the EASL #LiverCancerSummit 2026, the leading global meeting on liver tumours. The programme will cover: 🔬 Basic, translational and clinical research 🌍 Cutting-edge insights from international experts 💡 Discussions shaping the future of liver cancer care 📢 Abstract deadline: 21 October 2025 easl.eu/event/liver-cancer-s… Don’t miss your chance to present your research and connect with the global liver cancer community. 💡 Register early: 28 October easl.eu/event/liver-cancer-s… #LiverTwitter #LiverX

Save the date for the upcoming EASL Molecular Tumour Board, taking place Wednesday 15 October at 18:00 CEST! Experts @VChernyakMD, @ma5RN, @MarcoSanduzzi, @siadaniela and @Vaital73 will discuss a case of HCC-neuroendocrine transition. Register now: easl-eu.zoom.us/webinar/regi… #LiverTwitter #LiverX

🎗️Join us at the EASL #LiverCancerSummit 2026 📅 22–24 January 📍 Edinburgh, UK Each day promises new highlights in the field of liver tumours. Browse the full programme to create an agenda tailored to your interests! 👉easl.eu/event/liver-cancer-s… Day 1: #MASLD and #HCC links, novel surveillance and biomarkers, AI, and emerging molecular therapies. Day 2: Advances in surgery, transplant, locoregional therapies, pivotal trials, and debates in liver cancer care. Day 3: Systemic therapies, treatment sequencing, immunotherapy, and the future of biomarker-driven, equitable, patient-centred care. 👉 Submit your abstract by 21 October easl.eu/event/liver-cancer-s… 👉 Register with early fees by 28 October easl.eu/event/liver-cancer-s… @DebbieShawcros1 @analleo @DJPinato @IreneBargellini @DJPinato @PinterMatthias

🎗️Register and submit your abstract to the EASL Liver Cancer Summit 2026, 22-24 January, Edinburgh, UK. The leading global event for liver cancer research and clinical practice is back. 🔬 Rapid advances in #HCC and #CCA are transforming treatment strategies, from immunotherapy and novel systemic therapies to AI-driven diagnostics. ✨ Why attend? ✔️ Learn the latest on primary liver cancer science and care ✔️ Connect with global experts in a dynamic, collaborative setting ✔️ Gain fresh insights into trials, guidelines, and personalised treatment Join the global liver cancer community and shape the future of patient care. 👉21 October: Abstract submission 👉28 October: Early Fee Registration easl.eu/event/liver-cancer-s… @IreneBargellini @DJPinato @PinterMatthias @EASLedu @DebbieShawcros1 @analleo

EASL is deeply saddened to share the news of the passing of Professor Michael P. Manns (1951–2025). A visionary leader in hepatology, Professor Manns shaped the field through his pioneering research in viral hepatitis, autoimmune liver diseases, transplantation and regenerative medicine. He served as Director of the Department of Gastroenterology, Hepatology and Endocrinology at Hannover Medical School for nearly three decades, and held leading roles in Hep-Net, the German Liver Foundation, UEG, and EASL. His scientific excellence, dedication and mentorship inspired colleagues around the world. Professor Manns received numerous awards, including the EASL Recognition Award (2007) and the UEG Lifetime Achievement Award (2022). EASL extends heartfelt condolences to his family, friends and colleagues. His legacy will continue to inspire generations of hepatologists.

🌟 Registration and abstract submission now open for the EASL Liver Cancer Summit 2026! 🌟 🗓️ 22–24 January 2026 📍 Edinburgh, UK Join the global liver cancer community for three transformative days of science, innovation, and collaboration. The EASL Liver Cancer Summit is the meeting for everyone involved in the care, research, and advocacy of liver cancer. Key Deadlines: 📌 Abstract submission: 11 August – 21 October 2025 📌 Early registration: 11 August – 28 October 2025 👉Secure your spot & send in your research: easl.eu/event/liver-cancer-s… @DebbieShawcros1 @analleo @DJPinato @BargelliniIrene @PinterMatthias

🆕We are excited to announce the launch of the new Fellowship Programme! Are you looking to grow your skills and connect with peers across Europe? Do you want to advance your research in liver disease? Discover our two fellowship types and apply by 1 September 2025! 🔗 easl.eu/fellowship/mobility-… #LiverTwitter #LiverX